{"pmid":32386438,"title":"\"Toxic erythema\" and eosinophilia associated to tocilizumab therapy in a COVID-19 patient.","text":["\"Toxic erythema\" and eosinophilia associated to tocilizumab therapy in a COVID-19 patient.","Since the new fatal pneumonia was identified in December 2019 in Wuhan, China, the WHO declared the infection a health emergency of international concern. The novel ss-RNA ss-coronavirus (SARS-CoV-2) spreads through airborne and direct contagion; virulence is high in the elderly and in patients with diabetes, chronic pulmonary, cardiovascular and neoplastic diseases. SARS-CoV-2 ssRNA is recognized by intracellular Pattern Recognition Receptors (PRRs), which trigger NF-kB - the master regulator of inflammation - and Interferon Regulatory Factors (IRFs)(1) .","J Eur Acad Dermatol Venereol","Sernicola, A","Carnicelli, G","Di Fraia, M","Chello, C","Furlan, C","Muharremi, R","Paolino, G","Grieco, T","32386438"],"abstract":["Since the new fatal pneumonia was identified in December 2019 in Wuhan, China, the WHO declared the infection a health emergency of international concern. The novel ss-RNA ss-coronavirus (SARS-CoV-2) spreads through airborne and direct contagion; virulence is high in the elderly and in patients with diabetes, chronic pulmonary, cardiovascular and neoplastic diseases. SARS-CoV-2 ssRNA is recognized by intracellular Pattern Recognition Receptors (PRRs), which trigger NF-kB - the master regulator of inflammation - and Interferon Regulatory Factors (IRFs)(1) ."],"journal":"J Eur Acad Dermatol Venereol","authors":["Sernicola, A","Carnicelli, G","Di Fraia, M","Chello, C","Furlan, C","Muharremi, R","Paolino, G","Grieco, T"],"date":"2020-05-10T11:00:00Z","year":2020,"_id":"32386438","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.1111/jdv.16620","keywords":["covid-19","drug eruption","eosinophilia","tocilizumab"],"locations":["Wuhan","China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Treatment","Mechanism"],"weight":1,"_version_":1666340101979897856,"score":9.490897,"similar":[{"pmid":32361001,"pmcid":"PMC7192074","title":"Bioinformatic analysis and identification of single-stranded RNA sequences recognized by TLR7/8 in the SARS-CoV-2, SARS-CoV, and MERS-CoV genomes.","text":["Bioinformatic analysis and identification of single-stranded RNA sequences recognized by TLR7/8 in the SARS-CoV-2, SARS-CoV, and MERS-CoV genomes.","During virus infection, host toll-like receptors (TLRs) can recognize different pathogen-associated molecular patterns and trigger the innate immune response. TLR7/8 can identify the single-stranded RNA (ssRNA) of the virus. This study aimed to search ssRNA sequences recognized by TLR7/8 from the SARS-CoV-2, SARS-CoV, and MERS-CoV whole genomes by a bioinformatic technique. The immunoinformatic approach showed that the SARS-CoV-2 genome has more ssRNA fragments that could be recognized by TLR7/8 than the SARS-CoV genome. These findings suggest innate immune hyperactivation by SARS-CoV-2. This activity is possibly able to provoke a robust proinflammatory response via TLR7/8 recognition and cause acute lung injury.","Microbes Infect","Moreno-Eutimio, Mario Adan","Lopez-Macias, Constantino","Pastelin-Palacios, Rodolfo","32361001"],"abstract":["During virus infection, host toll-like receptors (TLRs) can recognize different pathogen-associated molecular patterns and trigger the innate immune response. TLR7/8 can identify the single-stranded RNA (ssRNA) of the virus. This study aimed to search ssRNA sequences recognized by TLR7/8 from the SARS-CoV-2, SARS-CoV, and MERS-CoV whole genomes by a bioinformatic technique. The immunoinformatic approach showed that the SARS-CoV-2 genome has more ssRNA fragments that could be recognized by TLR7/8 than the SARS-CoV genome. These findings suggest innate immune hyperactivation by SARS-CoV-2. This activity is possibly able to provoke a robust proinflammatory response via TLR7/8 recognition and cause acute lung injury."],"journal":"Microbes Infect","authors":["Moreno-Eutimio, Mario Adan","Lopez-Macias, Constantino","Pastelin-Palacios, Rodolfo"],"date":"2020-05-04T11:00:00Z","year":2020,"_id":"32361001","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.1016/j.micinf.2020.04.009","keywords":["mers","sars","sars-cov-2","tlr7","tlr8"],"topics":["Mechanism"],"weight":1,"_version_":1666138495927713792,"score":142.68929},{"pmid":32187007,"title":"Identifying and Interrupting Superspreading Events-Implications for Control of Severe Acute Respiratory Syndrome Coronavirus 2.","text":["Identifying and Interrupting Superspreading Events-Implications for Control of Severe Acute Respiratory Syndrome Coronavirus 2.","It appears inevitable that severe acute respiratory syndrome coronavirus 2 will continue to spread. Although we still have limited information on the epidemiology of this virus, there have been multiple reports of superspreading events (SSEs), which are associated with both explosive growth early in an outbreak and sustained transmission in later stages. Although SSEs appear to be difficult to predict and therefore difficult to prevent, core public health actions can prevent and reduce the number and impact of SSEs. To prevent and control of SSEs, speed is essential. Prevention and mitigation of SSEs depends, first and foremost, on quickly recognizing and understanding these events, particularly within healthcare settings. Better understanding transmission dynamics associated with SSEs, identifying and mitigating high-risk settings, strict adherence to healthcare infection prevention and control measures, and timely implementation of nonpharmaceutical interventions can help prevent and control severe acute respiratory syndrome coronavirus 2, as well as future infectious disease outbreaks.","Emerg Infect Dis","Frieden, Thomas R","Lee, Christopher T","32187007"],"abstract":["It appears inevitable that severe acute respiratory syndrome coronavirus 2 will continue to spread. Although we still have limited information on the epidemiology of this virus, there have been multiple reports of superspreading events (SSEs), which are associated with both explosive growth early in an outbreak and sustained transmission in later stages. Although SSEs appear to be difficult to predict and therefore difficult to prevent, core public health actions can prevent and reduce the number and impact of SSEs. To prevent and control of SSEs, speed is essential. Prevention and mitigation of SSEs depends, first and foremost, on quickly recognizing and understanding these events, particularly within healthcare settings. Better understanding transmission dynamics associated with SSEs, identifying and mitigating high-risk settings, strict adherence to healthcare infection prevention and control measures, and timely implementation of nonpharmaceutical interventions can help prevent and control severe acute respiratory syndrome coronavirus 2, as well as future infectious disease outbreaks."],"journal":"Emerg Infect Dis","authors":["Frieden, Thomas R","Lee, Christopher T"],"date":"2020-03-19T11:00:00Z","year":2020,"_id":"32187007","source":"PubMed","week":"202012|Mar 16 - Mar 22","doi":"10.3201/eid2606.200495","keywords":["2019 novel coronavirus disease","covid-19","sars-cov-2","sses","behavioral factors","coronavirus","disease control","environmental factors","host factors","outbreaks","pathogen-specific factors","respiratory infections","response factors","severe acute respiratory syndrome coronavirus 2","superspreading events","viruses","zoonoses"],"topics":["Transmission","Prevention"],"weight":1,"_version_":1666138492522987523,"score":125.76226},{"pmid":32482373,"title":"Tocilizumab: A Therapeutic Option for the Treatment of Cytokine Storm Syndrome in COVID-19.","text":["Tocilizumab: A Therapeutic Option for the Treatment of Cytokine Storm Syndrome in COVID-19.","Presently, we need more therapeutic molecules for this COVID-19 outbreak. The severity and mortality of the disease is associated with a high level of release of cytokine in the patients which is known as CRS (cytokine release syndrome) or cytokine storm syndrome. IL-6 is a type of pro-inflammatory cytokine which release in the severe COVID-19 patients. This cytokine initiates CRS the JAK-STAT or MAPK/NF-kappaB-IL-6 pathway. Tocilizumab, a humanized monoclonal antibody, is designed to bind both mIL-6R (membrane bound receptor for IL-6) and sIL-6R (soluble receptor for IL-6) and inhibit the JAK-STAT or MAPK/NF-kappaB-IL-6 signaling pathway. It finally stops the cytokine storm syndrome. However, we need to understand that how tocilizumab is bound with mIL-6R or sIL-6R. Similarly, we also need to understand more about the real molecular mechanism of activity of tocilizumab.","Arch Med Res","Saha, Abinit","Sharma, Ashish Ranjan","Bhattacharya, Manojit","Sharma, Garima","Lee, Sang-Soo","Chakraborty, Chiranjib","32482373"],"abstract":["Presently, we need more therapeutic molecules for this COVID-19 outbreak. The severity and mortality of the disease is associated with a high level of release of cytokine in the patients which is known as CRS (cytokine release syndrome) or cytokine storm syndrome. IL-6 is a type of pro-inflammatory cytokine which release in the severe COVID-19 patients. This cytokine initiates CRS the JAK-STAT or MAPK/NF-kappaB-IL-6 pathway. Tocilizumab, a humanized monoclonal antibody, is designed to bind both mIL-6R (membrane bound receptor for IL-6) and sIL-6R (soluble receptor for IL-6) and inhibit the JAK-STAT or MAPK/NF-kappaB-IL-6 signaling pathway. It finally stops the cytokine storm syndrome. However, we need to understand that how tocilizumab is bound with mIL-6R or sIL-6R. Similarly, we also need to understand more about the real molecular mechanism of activity of tocilizumab."],"journal":"Arch Med Res","authors":["Saha, Abinit","Sharma, Ashish Ranjan","Bhattacharya, Manojit","Sharma, Garima","Lee, Sang-Soo","Chakraborty, Chiranjib"],"date":"2020-06-03T11:00:00Z","year":2020,"_id":"32482373","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1016/j.arcmed.2020.05.009","keywords":["covid-19","cytokine storm syndrome","therapeutic option","tocilizumab"],"e_drugs":["tocilizumab"],"topics":["Treatment","Mechanism"],"weight":1,"_version_":1668532114882035712,"score":118.396324},{"pmid":32408070,"pmcid":"PMC7202847","title":"Does zinc supplementation enhance the clinical efficacy of chloroquine/hydroxychloroquine to win today's battle against COVID-19?","text":["Does zinc supplementation enhance the clinical efficacy of chloroquine/hydroxychloroquine to win today's battle against COVID-19?","Currently, drug repurposing is an alternative to novel drug development for the treatment of COVID-19 patients. The antimalarial drug chloroquine (CQ) and its metabolite hydroxychloroquine (HCQ) are currently being tested in several clinical studies as potential candidates to limit SARS-CoV-2-mediated morbidity and mortality. CQ and HCQ (CQ/HCQ) inhibit pH-dependent steps of SARS-CoV-2 replication by increasing pH in intracellular vesicles and interfere with virus particle delivery into host cells. Besides direct antiviral effects, CQ/HCQ specifically target extracellular zinc to intracellular lysosomes where it interferes with RNA-dependent RNA polymerase activity and coronavirus replication. As zinc deficiency frequently occurs in elderly patients and in those with cardiovascular disease, chronic pulmonary disease, or diabetes, we hypothesize that CQ/HCQ plus zinc supplementation may be more effective in reducing COVID-19 morbidity and mortality than CQ or HCQ in monotherapy. Therefore, CQ/HCQ in combination with zinc should be considered as additional study arm for COVID-19 clinical trials.","Med Hypotheses","Derwand, R","Scholz, M","32408070"],"abstract":["Currently, drug repurposing is an alternative to novel drug development for the treatment of COVID-19 patients. The antimalarial drug chloroquine (CQ) and its metabolite hydroxychloroquine (HCQ) are currently being tested in several clinical studies as potential candidates to limit SARS-CoV-2-mediated morbidity and mortality. CQ and HCQ (CQ/HCQ) inhibit pH-dependent steps of SARS-CoV-2 replication by increasing pH in intracellular vesicles and interfere with virus particle delivery into host cells. Besides direct antiviral effects, CQ/HCQ specifically target extracellular zinc to intracellular lysosomes where it interferes with RNA-dependent RNA polymerase activity and coronavirus replication. As zinc deficiency frequently occurs in elderly patients and in those with cardiovascular disease, chronic pulmonary disease, or diabetes, we hypothesize that CQ/HCQ plus zinc supplementation may be more effective in reducing COVID-19 morbidity and mortality than CQ or HCQ in monotherapy. Therefore, CQ/HCQ in combination with zinc should be considered as additional study arm for COVID-19 clinical trials."],"journal":"Med Hypotheses","authors":["Derwand, R","Scholz, M"],"date":"2020-05-15T11:00:00Z","year":2020,"_id":"32408070","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1016/j.mehy.2020.109815","keywords":["covid-19","chloroquine","hydroxychloroquine","sars-cov-2","therapy","zinc"],"e_drugs":["Hydroxychloroquine","Chloroquine"],"topics":["Treatment","Mechanism"],"weight":1,"_version_":1666950579753058304,"score":109.34723},{"pmid":32468998,"title":"Factors Associated with Resilience Among Medical Staff in Radiology Departments During The Outbreak of 2019 Novel Coronavirus Disease (COVID-19): A Cross-Sectional Study.","text":["Factors Associated with Resilience Among Medical Staff in Radiology Departments During The Outbreak of 2019 Novel Coronavirus Disease (COVID-19): A Cross-Sectional Study.","BACKGROUND A growing body of evidence suggests that in the face of life adversity, threats, or other major stressful events, resilience is more conducive to individual adaptation and growth. MATERIAL AND METHODS The Connor-Davidson Resilience Scale and the Chinese Perceived Stress Scale were used to evaluate the resilience and perceived stress of 600 medical staff members from the radiology departments in 32 public hospitals in Sichuan Province, China, respectively. Multiple linear regression was used to analyze factors related to resilience. RESULTS The total resilience score was 65.76+/-17.26, wherein the toughness dimension score was 33.61+/-9.52, the strength dimension score was 21.25+/-5.50, and the optimism dimension score was 10.91+/-3.15. There was a significant negative correlation between perceived stress and resilience (r=-0.635, P<0.001). According to multivariate analysis, the total perceived stress score (ss=-1.318, P<0.001), gender (ss=-4.738, P<0.001), knowledge of COVID-19 (ss=2.884, P=0.043), knowledge of COVID-19 protective measures (ss=3.260, P=0.042), and availability of adequate protective materials (ss=-1.268, P=0.039) were independent influencing factors for resilience. CONCLUSIONS The resilience level of the medical staff in the radiology departments during the outbreak of COVID-19 was generally low, particularly regarding toughness. More attention should be paid to resilience influence factors such as high perceived stress, female gender, lack of understanding of COVID-19 and protective measures, and lack of protective materials, and targeted interventions should be undertaken to improve the resilience level of the medical staff in the radiology departments during the outbreak of COVID-19.","Med Sci Monit","Huang, Lei","Wang, Yun","Liu, Juan","Ye, Pengfei","Cheng, Bochao","Xu, Huayan","Qu, Haibo","Ning, Gang","32468998"],"abstract":["BACKGROUND A growing body of evidence suggests that in the face of life adversity, threats, or other major stressful events, resilience is more conducive to individual adaptation and growth. MATERIAL AND METHODS The Connor-Davidson Resilience Scale and the Chinese Perceived Stress Scale were used to evaluate the resilience and perceived stress of 600 medical staff members from the radiology departments in 32 public hospitals in Sichuan Province, China, respectively. Multiple linear regression was used to analyze factors related to resilience. RESULTS The total resilience score was 65.76+/-17.26, wherein the toughness dimension score was 33.61+/-9.52, the strength dimension score was 21.25+/-5.50, and the optimism dimension score was 10.91+/-3.15. There was a significant negative correlation between perceived stress and resilience (r=-0.635, P<0.001). According to multivariate analysis, the total perceived stress score (ss=-1.318, P<0.001), gender (ss=-4.738, P<0.001), knowledge of COVID-19 (ss=2.884, P=0.043), knowledge of COVID-19 protective measures (ss=3.260, P=0.042), and availability of adequate protective materials (ss=-1.268, P=0.039) were independent influencing factors for resilience. CONCLUSIONS The resilience level of the medical staff in the radiology departments during the outbreak of COVID-19 was generally low, particularly regarding toughness. More attention should be paid to resilience influence factors such as high perceived stress, female gender, lack of understanding of COVID-19 and protective measures, and lack of protective materials, and targeted interventions should be undertaken to improve the resilience level of the medical staff in the radiology departments during the outbreak of COVID-19."],"journal":"Med Sci Monit","authors":["Huang, Lei","Wang, Yun","Liu, Juan","Ye, Pengfei","Cheng, Bochao","Xu, Huayan","Qu, Haibo","Ning, Gang"],"date":"2020-05-30T11:00:00Z","year":2020,"_id":"32468998","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.12659/MSM.925669","locations":["Sichuan","China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Prevention"],"weight":1,"_version_":1668167109890277376,"score":108.93889}]}